• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

循环细胞游离 DNA 作为乙酰氨基酚诱导肝损伤的生物标志物和治疗靶点。

Circulating Cell-Free DNAs as a Biomarker and Therapeutic Target for Acetaminophen-Induced Liver Injury.

机构信息

School of Biomedical Sciences and Engineering, South China University of Technology, Guangzhou International Campus, Guangzhou, Guangdong, 510630, China.

National Engineering Research Center for Tissue Restoration and Reconstruction, South China University of Technology, Guangzhou International Campus, Guangzhou, Guangdong, 510630, China.

出版信息

Adv Sci (Weinh). 2023 Jun;10(16):e2206789. doi: 10.1002/advs.202206789. Epub 2023 Apr 10.

DOI:10.1002/advs.202206789
PMID:37035952
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10238175/
Abstract

Acetaminophen (APAP) overdose is a leading cause of drug-induced liver injury and acute liver failure, while the detection, prognosis prediction, and therapy for APAP-induced liver injury (AILI) remain improved. Here, it is determined that the temporal pattern of circulating cell-free DNA (cfDNA) is strongly associated with damage and inflammation parameters in AILI. CfDNA is comparable to alanine aminotransferase (ALT) in predicting mortality and outperformed ALT when combined with ALT in AILI. The depletion of cfDNA or neutrophils alleviates liver damage, while the addition of cfDNA or adoptive transfer of neutrophils exacerbates the damage. The combination of DNase I and N-acetylcysteine attenuates AILI significantly. This study establishes that cfDNA is a mechanistic biomarker to predict mortality in AILI mice. The combination of scavenging cfDNA and reducing oxidative damage provides a promising treatment for AILI.

摘要

对乙酰氨基酚(APAP)过量是药物性肝损伤和急性肝衰竭的主要原因,而 APAP 诱导的肝损伤(AILI)的检测、预后预测和治疗仍有待改善。在这里,确定循环无细胞 DNA(cfDNA)的时间模式与 AILI 中的损伤和炎症参数密切相关。cfDNA 在预测死亡率方面与丙氨酸氨基转移酶(ALT)相当,并且在与 ALT 联合使用时优于 ALT 在 AILI 中的表现。cfDNA 或中性粒细胞的耗竭可减轻肝损伤,而 cfDNA 的添加或中性粒细胞的过继转移则可加重损伤。DNase I 和 N-乙酰半胱氨酸的联合使用可显著减轻 AILI。本研究确立了 cfDNA 是预测 AILI 小鼠死亡率的机制生物标志物。cfDNA 的清除和氧化损伤的减少相结合,为 AILI 的治疗提供了一种很有前途的方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fa4/10238175/3c1c3da7e7be/ADVS-10-2206789-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fa4/10238175/a4bf752fbebf/ADVS-10-2206789-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fa4/10238175/aa9643a4738b/ADVS-10-2206789-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fa4/10238175/0f2805cac2a7/ADVS-10-2206789-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fa4/10238175/645ac76c51bd/ADVS-10-2206789-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fa4/10238175/b7a632321b69/ADVS-10-2206789-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fa4/10238175/3c1c3da7e7be/ADVS-10-2206789-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fa4/10238175/a4bf752fbebf/ADVS-10-2206789-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fa4/10238175/aa9643a4738b/ADVS-10-2206789-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fa4/10238175/0f2805cac2a7/ADVS-10-2206789-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fa4/10238175/645ac76c51bd/ADVS-10-2206789-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fa4/10238175/b7a632321b69/ADVS-10-2206789-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fa4/10238175/3c1c3da7e7be/ADVS-10-2206789-g001.jpg

相似文献

1
Circulating Cell-Free DNAs as a Biomarker and Therapeutic Target for Acetaminophen-Induced Liver Injury.循环细胞游离 DNA 作为乙酰氨基酚诱导肝损伤的生物标志物和治疗靶点。
Adv Sci (Weinh). 2023 Jun;10(16):e2206789. doi: 10.1002/advs.202206789. Epub 2023 Apr 10.
2
Cathelicidin promotes liver repair after acetaminophen-induced liver injury in mice.在小鼠中,杀菌肽促进对乙酰氨基酚诱导的肝损伤后的肝脏修复。
JHEP Rep. 2023 Jan 31;5(4):100687. doi: 10.1016/j.jhepr.2023.100687. eCollection 2023 Apr.
3
Chitinase 3-like-1 contributes to acetaminophen-induced liver injury by promoting hepatic platelet recruitment.几丁质酶 3 样蛋白 1 通过促进肝内血小板募集促进对乙酰氨基酚诱导的肝损伤。
Elife. 2021 Jun 10;10:e68571. doi: 10.7554/eLife.68571.
4
Role of caspase-8 and/or -9 as biomarkers that can distinguish the potential to cause toxic- and immune related-adverse event, for the progress of acetaminophen-induced liver injury.半胱天冬氨酸蛋白酶-8 和/或 -9 作为生物标志物在区分潜在的毒性和免疫相关不良事件中的作用,用于进展性对乙酰氨基酚诱导的肝损伤。
Life Sci. 2022 Apr 1;294:120351. doi: 10.1016/j.lfs.2022.120351. Epub 2022 Jan 29.
5
Decreased plasma acetaminophen glucuronide/acetaminophen concentration ratio warns the onset of acetaminophen-induced liver injury.血浆对乙酰氨基酚葡萄糖醛酸苷/对乙酰氨基酚浓度比值降低预示着对乙酰氨基酚诱导的肝损伤的发生。
Biopharm Drug Dispos. 2022 Jun;43(3):108-116. doi: 10.1002/bdd.2316. Epub 2022 May 17.
6
P2rx1 deficiency alleviates acetaminophen-induced acute liver failure by regulating the STING signaling pathway.P2rx1 缺失通过调控 STING 信号通路缓解对乙酰氨基酚诱导的急性肝衰竭。
Cell Biol Toxicol. 2023 Dec;39(6):2761-2774. doi: 10.1007/s10565-023-09800-1. Epub 2023 Apr 13.
7
Galangin Prevents Acute Hepatorenal Toxicity in Novel Propacetamol-Induced Acetaminophen-Overdosed Mice.高良姜预防新型丙帕他莫诱导的对乙酰氨基酚过量小鼠的急性肝肾毒性。
J Med Food. 2015 Nov;18(11):1187-97. doi: 10.1089/jmf.2014.3328. Epub 2015 Jun 4.
8
Combination of sivelestat and N-acetylcysteine alleviates the inflammatory response and exceeds standard treatment for acetaminophen-induced liver injury.西维来司他联合 N-乙酰半胱氨酸减轻了对乙酰氨基酚诱导的肝损伤的炎症反应,优于标准治疗。
J Leukoc Biol. 2020 Feb;107(2):341-355. doi: 10.1002/JLB.5A1119-279R. Epub 2019 Dec 16.
9
Molecular pathogenesis of acetaminophen-induced liver injury and its treatment options.对乙酰氨基酚诱导的肝损伤的分子发病机制及其治疗选择。
J Zhejiang Univ Sci B. 2022 Apr 15;23(4):265-285. doi: 10.1631/jzus.B2100977.
10
Loss of Ninjurin1 alleviates acetaminophen-induced liver injury via enhancing AMPKα-NRF2 pathway.Ninjurin1 的缺失通过增强 AMPKα-NRF2 通路减轻对乙酰氨基酚诱导的肝损伤。
Life Sci. 2024 Aug 1;350:122782. doi: 10.1016/j.lfs.2024.122782. Epub 2024 Jun 6.

引用本文的文献

1
Gene hydrogel platforms for targeted skin therapy: bridging hereditary disorders, chronic wounds, and immune related skin diseases.用于靶向皮肤治疗的基因水凝胶平台:连接遗传性疾病、慢性伤口和免疫相关皮肤病。
Front Drug Deliv. 2025 Jul 1;5:1598145. doi: 10.3389/fddev.2025.1598145. eCollection 2025.
2
Myeloperoxidase, extracellular DNA and neutrophil extracellular trap formation in the animal models of metabolic dysfunction-associated steatotic liver disease.代谢功能障碍相关脂肪性肝病动物模型中的髓过氧化物酶、细胞外DNA与中性粒细胞胞外诱捕网形成
World J Gastroenterol. 2025 Jul 21;31(27):106166. doi: 10.3748/wjg.v31.i27.106166.
3

本文引用的文献

1
A nanoparticulate dual scavenger for targeted therapy of inflammatory bowel disease.一种用于炎症性肠病靶向治疗的纳米颗粒双清除剂。
Sci Adv. 2022 Jan 28;8(4):eabj2372. doi: 10.1126/sciadv.abj2372.
2
Recommendations for the use of the acetaminophen hepatotoxicity model for mechanistic studies and how to avoid common pitfalls.对用于机制研究的对乙酰氨基酚肝毒性模型的使用建议以及如何避免常见陷阱。
Acta Pharm Sin B. 2021 Dec;11(12):3740-3755. doi: 10.1016/j.apsb.2021.09.023. Epub 2021 Sep 30.
3
Generation of neutrophil extracellular traps in patients with acute liver failure is associated with poor outcome.
IDO1 promotes Echinococcus multilocularis infection by regulating the formation of neutrophil extracellular traps.
吲哚胺2,3-双加氧酶1通过调节中性粒细胞胞外诱捕网的形成促进多房棘球绦虫感染。
Vet Res. 2025 Jul 1;56(1):131. doi: 10.1186/s13567-025-01572-2.
4
Therapeutic Effects of DNase I on Peripheral and Local Markers of Liver Injury and Neutrophil Extracellular Traps in a Model of Alcohol-Related Liver Disease.脱氧核糖核酸酶I对酒精性肝病模型中肝损伤的外周和局部标志物及中性粒细胞胞外陷阱的治疗作用
Int J Mol Sci. 2025 Feb 22;26(5):1893. doi: 10.3390/ijms26051893.
5
Multifunctional nanoparticles confers both multiple inflammatory mediators scavenging and macrophage polarization for sepsis therapy.多功能纳米颗粒兼具清除多种炎症介质和使巨噬细胞极化的作用,用于脓毒症治疗。
Mater Today Bio. 2024 Dec 20;30:101421. doi: 10.1016/j.mtbio.2024.101421. eCollection 2025 Feb.
6
Enzyme-Responsive Nanoparachute for Targeted miRNA Delivery: A Protective Strategy Against Acute Liver and Kidney Injury.用于靶向递送微小RNA的酶响应性纳米降落伞:一种针对急性肝肾损伤的保护策略
Adv Sci (Weinh). 2025 Mar;12(10):e2411210. doi: 10.1002/advs.202411210. Epub 2024 Dec 24.
7
Nanomaterial-Mediated Reprogramming of Macrophages to Inhibit Refractory Muscle Fibrosis.纳米材料介导的巨噬细胞重编程以抑制难治性肌肉纤维化
Adv Mater. 2024 Dec;36(52):e2410368. doi: 10.1002/adma.202410368. Epub 2024 Nov 16.
8
Investigation of Extracted Plasma Cell-Free DNA as a Biomarker in Foals with Sepsis.提取的血浆游离DNA作为脓毒症马驹生物标志物的研究。
Vet Sci. 2024 Aug 1;11(8):346. doi: 10.3390/vetsci11080346.
9
Myeloid-Mas Signaling Modulates Pathogenic Crosstalk among MYCCD63 Endothelial Cells, MMP12 Macrophages, and Monocytes in Acetaminophen-Induced Liver Injury.髓系-Mas信号传导调节对乙酰氨基酚诱导的肝损伤中MYCCD63内皮细胞、MMP12巨噬细胞和单核细胞之间的致病性串扰。
Adv Sci (Weinh). 2024 Apr;11(16):e2306066. doi: 10.1002/advs.202306066. Epub 2024 Feb 13.
10
Hepatic-Accumulated Obeticholic Acid and Atorvastatin Self-Assembled Nanocrystals Potentiate Ameliorative Effects in Treatment of Metabolic-Associated Fatty Liver Disease.肝脏蓄积的奥贝胆酸和阿托伐他汀自组装纳米晶体增强对代谢相关脂肪性肝病的改善作用。
Adv Sci (Weinh). 2024 Mar;11(10):e2308866. doi: 10.1002/advs.202308866. Epub 2024 Jan 9.
急性肝衰竭患者中性粒细胞胞外诱捕网的产生与不良预后相关。
Hepatology. 2022 Mar;75(3):623-633. doi: 10.1002/hep.32174. Epub 2021 Dec 12.
4
Significance of Circulating Cell-Free DNA Species in Non-Alcoholic Fatty Liver Disease.循环游离 DNA 种类在非酒精性脂肪性肝病中的意义。
Int J Mol Sci. 2021 Aug 17;22(16):8849. doi: 10.3390/ijms22168849.
5
Cell-free DNA beyond a biomarker for rejection: Biological trigger of tissue injury and potential therapeutics.游离DNA不止是排斥反应的生物标志物:组织损伤的生物学触发因素及潜在治疗方法
J Heart Lung Transplant. 2021 Jun;40(6):405-413. doi: 10.1016/j.healun.2021.03.007. Epub 2021 Mar 24.
6
Epigenetics, fragmentomics, and topology of cell-free DNA in liquid biopsies.液体活检中游离 DNA 的表观遗传学、片段组学和拓扑结构。
Science. 2021 Apr 9;372(6538). doi: 10.1126/science.aaw3616.
7
Cell-free DNA maps COVID-19 tissue injury and risk of death and can cause tissue injury.无细胞 DNA 可绘制 COVID-19 组织损伤和死亡风险图谱,并可能导致组织损伤。
JCI Insight. 2021 Apr 8;6(7):147610. doi: 10.1172/jci.insight.147610.
8
Cell-free DNA tissues of origin by methylation profiling reveals significant cell, tissue, and organ-specific injury related to COVID-19 severity.通过甲基化分析鉴定无细胞游离 DNA 的组织起源,揭示了与 COVID-19 严重程度相关的显著的细胞、组织和器官特异性损伤。
Med. 2021 Apr 9;2(4):411-422.e5. doi: 10.1016/j.medj.2021.01.001. Epub 2021 Jan 16.
9
Advances in biomarker development in acetaminophen toxicity.在对乙酰氨基酚毒性的生物标志物开发方面的进展。
Adv Clin Chem. 2020;98:35-50. doi: 10.1016/bs.acc.2020.02.002. Epub 2020 Apr 27.
10
Treatment of severe sepsis with nanoparticulate cell-free DNA scavengers.纳米颗粒无细胞 DNA 清除剂治疗严重脓毒症。
Sci Adv. 2020 May 29;6(22):eaay7148. doi: 10.1126/sciadv.aay7148. eCollection 2020 May.